SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

GSK Wins FDA Accelerated Approval for Nelkarmi in ALK-Positive NSCLC

The FDA granted accelerated approval for Nelkarmi for adults with locally advanced or metastatic ALK-positive NSCLC.

GSK

Related stories